Morgan Stanley Upgrades Axsome Therapeutics (AXSM) to Overweight, 'attractive risk/reward heading into 2H24'

Go back to Morgan Stanley Upgrades Axsome Therapeutics (AXSM) to Overweight, 'attractive risk/reward heading into 2H24'
(NASDAQ: AXSM) Delayed: 216.27 +2.60 (1.22%)
Previous Close $213.67    52 Week High $15.74 
Open $212.01    52 Week Low $5.37 
Day High $216.96    P/E N/A 
Day Low $211.44    EPS $0.00 
Volume 497,498